DRESS syndrome associated with HHV-6 reactivation

European Journal of Internal Medicine

Volumn 14, Issue 8, 2003, Pages 498-500

  Ichiche, Malika ^a   Kiesch, Nelly ^b   De Bels, David ^b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Corticosteroids; Drug reaction; Eosinophilia; Hepatitis; HHV 6

Indexed keywords

BISOPROLOL; CAPTOPRIL; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE;

AGED; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEATH; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME; EOSINOPHILIA; FACE EDEMA; FEMALE; FEVER; HEART FAILURE; HEPATITIS; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; HYPEREOSINOPHILIA; KIDNEY FAILURE; LABORATORY TEST; MYALGIA; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRURITUS; RASH; SEROLOGY; SKIN BIOPSY; SYSTEMIC DISEASE; VIRUS DIAGNOSIS; VIRUS REACTIVATION;

EID: 1142309726     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2003.09.004     Document Type: Article

References (11)

1. Roujeau J.C., Stern R.S. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331:1994;1272-1285.
2. Shear N.H., Spielberg S.P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J. Clin. Invest. 82:1988;1826-1832.
3. Lanzafame M., Rovere P., De Checchi G., Trevenzoli M., Turazzini M., Parrinello A. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy. Scand. J. Infect. Dis. 33:2001;475-476.
4. Pirmohamed H., Kitteringham H.R., Park B.K. The role of active metabolites in drug toxicity. Drug Safety. 11:1994;114-144.
5. Descamps V., Bouscarat F., Laglenne S.et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br. J. Dermatol. 137:1997;605-608.
6. Descamps V., Valance A., Edlinger C.et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch. Dermatol. 137:2001;301-304.
7. Suzuki Y., Inagi R., Aono T., Yamanishi K., Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch. Dermatol. 134:1998;1108-1112.
8. Tohyama M., Yahata Y., Yasukawa M.et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch. Dermatol. 134:1998;1113-1117.
9. Callot V., Roujeau J.C., Bagot M.et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch. Dermatol. 132:1996;1315-1321.
10. Simonart T., Tugendhaft P., Vereecken P., de Dobbeleer G., Heenen M. Hazards of therapy with high doses of N-acetylcysteine for anticonvulsant- induced hypersensitivity syndrome. Br. J. Dermatol. 138:1998;553.
11. Bocquet H., Bagot M., Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin. Cutan. Med. Surg. 15:1996;250-257.